1. Home
  2. CRVS vs RCBC Comparison

CRVS vs RCBC Comparison

Compare CRVS & RCBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Corvus Pharmaceuticals Inc.

CRVS

Corvus Pharmaceuticals Inc.

HOLD

Current Price

$9.68

Market Cap

811.8M

Sector

Health Care

ML Signal

HOLD

Logo River City Bank Common stock

RCBC

River City Bank Common stock

N/A

Current Price

$53.77

Market Cap

736.3M

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
CRVS
RCBC
Founded
2014
1963
Country
United States
United States
Employees
37
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Major Banks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
811.8M
736.3M
IPO Year
2016
N/A

Fundamental Metrics

Financial Performance
Metric
CRVS
RCBC
Price
$9.68
$53.77
Analyst Decision
Strong Buy
Hold
Analyst Count
8
4
Target Price
$33.14
★ $56.00
AVG Volume (30 Days)
★ 1.0M
92.1K
Earning Date
11-03-2026
10-23-2026
Dividend Yield
N/A
★ 0.37%
EPS Growth
★ 48.04
N/A
EPS
N/A
★ N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$2.45
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$6.39
$46.34
52 Week High
$26.95
$56.71

Technical Indicators

Market Signals
Indicator
CRVS
RCBC
Relative Strength Index (RSI) 32.50 54.36
Support Level $6.39 $50.77
Resistance Level $13.73 $54.95
Average True Range (ATR) 0.58 1.54
MACD -0.04 -0.13
Stochastic Oscillator 17.38 52.38

Price Performance

Historical Comparison
CRVS
RCBC

About CRVS Corvus Pharmaceuticals Inc.

Corvus Pharmaceuticals Inc is a clinical stage biopharmaceutical company developing product candidates that precisely target proteins that are critical to immune cell maturation and function. It believes its proprietary product candidates have broad potential to address immune mediated diseases, inflammatory diseases and cancers. Its product candidate, soquelitinib, is designed to bind specifically to a protein, interleukin 2 inducible T cell kinase (ITK), involved in T cell activation, T cell receptor signaling and T cell differentiation and function. The company operates in one primary business activity and operate as one reportable segment.

About RCBC River City Bank Common stock

River City Bank is a California state-chartered bank engaged in providing a range of banking services to individuals and businesses in California. The company's primary deposit products are checking, savings, and term certificate accounts, and its primary lending products are commercial real estate, commercial, agriculture, residential mortgage, and consumer loans. Substantially all loans are secured by specific items of collateral, including business assets, consumer assets, and commercial and residential real estate in the Western United States.

Share on Social Networks: